New hope for toddlers with sickle cell: liquid medicine study aims to prevent painful crises
Disease control
Recruiting now
This study is checking the safety and real-world effectiveness of a liquid medicine called Xromi for very young children with sickle cell disease. It will follow about 180 children under 2 years old for two years, comparing those taking the medicine to similar children who are no…
Sponsor: Nova Laboratories Limited • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC